Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101519351B details indium-promoted synthesis offering high yield and mild conditions for scalable pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN114456121B reveals catalyst-free photochemical synthesis enabling cost reduction and supply chain reliability for high-purity pharmaceutical intermediate manufacturing.
Patent CN110305070B reveals a safer hydrazine hydrate route for tetrazoleacetic acid. Achieve >99% purity and significant cost reduction in antibiotic manufacturing.
Novel two-step synthesis for PARP-1 inhibitors ensures high purity. Optimized acyl chlorination and amidation reduce costs and improve supply chain reliability for pharmaceutical partners.
Patent CN101337970B details a novel synthesis for Cefpirome Sulfate offering high purity and scalable production for reliable antibiotic intermediate supply chains.
Patent CN111943967A reveals a cost-effective cobalt-catalyzed dehydroboration of olefins, offering high-purity alkenyl boronates for pharmaceutical intermediate manufacturing.
Novel metal-catalyzed cyclization for furan macrocycles. High atom economy, scalable route for optical materials and pharmaceutical intermediates.
Patent CN104058935B details high-purity synthesis route. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Advanced synthesis of 2-Boc-8-carboxyl-1,2,3,4-tetrahydroisoquinoline via patent CN117903052A. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN105254512B offers safer terbutaline sulfate synthesis. Eliminates high-pressure hydrogenation. Reliable supplier for pharma intermediates.
Novel copper-catalyzed route for high-purity trifluoromethylpyridine derivatives ensures significant cost reduction and enhanced supply chain stability for global pharmaceutical manufacturers seeking reliable intermediates.
Patent CN111393329A details a high-yield synthesis of BDH, a key ritonavir intermediate, utilizing stereoselective reduction for cost-effective manufacturing.
Novel synthesis route avoids azide risks and reduces steps for high-purity pharmaceutical intermediates manufacturing with significant cost advantages.
Patent CN115724792A reveals a streamlined ammonolysis route for Edoxaban intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Novel photocatalytic carbene route for high-purity intermediates. Reduces steps and enhances supply chain reliability for global pharmaceutical and polymer manufacturers seeking cost reduction.
Patent CN110483420A details rhodium-catalyzed tetrahydroquinoxaline synthesis using water. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107805225B reveals a green synthesis route for 5-mercapto tetrazole acetic acid, eliminating toxic methyl iodide and enabling cost-effective industrial scale-up for ceforanide production.
Patent CN1046709C details a scalable palladium-catalyzed vinyl substitution for pyridine derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111763150B reveals a novel L-glutamic acid resolution method for high-purity sertraline, offering significant cost reduction and supply chain reliability for global buyers.
Novel iodine-catalyzed method for 2-aminothiazoles offers cost reduction in pharma manufacturing. Mild conditions, high purity, scalable process for API intermediates.